Mount Sinai Leads Multi-Site Study Evaluating a Novel Intervention Designed to Improve Community Re-Entry Outcomes for Justice-Involved Individuals With Brain Injuries

Researchers from the Brain Injury Research Center at the Icahn School of Medicine at Mount Sinai, in partnership with the Pennsylvania Department of Corrections (PADOC) and the Brain Injury Assocation of Pennsylvania (BIAPA), have launched a rigorous research study to reduce recidivism, or re-offending, among people with brain injury who are leaving incarceration.

Penn Medicine Developed CAR T Cell Therapy Wins Third FDA Approval

The U.S. Food and Drug Administration (FDA) has expanded its approval for a personalized cellular therapy developed at the University of Pennsylvania’s Abramson Cancer Center, this time for the treatment of adults with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. The accelerated approval was granted today to Novartis for the chimeric antigen receptor (CAR) T-cell therapy Kymriah® (tisagenlecleucel), making it the third indication for the nation’s first personalized cellular therapy for cancer. It remains the only CAR-T cell therapy approved for both adult and pediatric patients.

Capturing Biogeochemical Details in River Corridor Models

In many streams and rivers, water moves between the open channel and the adjacent groundwater, enabling reactions that can remove or transform carbon, contaminants, and nutrients. Researchers developed a new modeling strategy to represent these effects in watershed-scale models. The new model addresses current models’ limited ability to simulate how carbon, nutrients, and contaminants move and transform in river corridors and allows for a new generation of research on river networks.

Blood Protein Levels and Birth Control Pills May Increase Blood Clot Risk in Female Astronauts

Article title: Albumin, oral contraceptives and venous thromboembolism risk in astronauts Authors: Sara R. Zwart, Serena M. Auñón-Chancellor, Martina Heer, M. Mark Melin, Scott M. Smith From the authors: “We report here evidence of an association between oral contraceptive use…

Chula Excellence Cancer Center collabs with medical specialists from various fields to enhance treatment capabilities.

Chula now has an Excellence Chulalongkorn Comprehensive Cancer Center bringing together medical specialists from various areas of expertise to attend to cancer patients using the latest academic and technological know-how to enhance the quality of life and the possibilities of being cured for patients of all types of cancer.

CityU co-hosts online science and tech conference with Nature journals; pre launch for CityU’s HK Tech Forum

Leading scientists exchanged innovative views on contemporary trends in the chemistry of 2D materials at a three-day online conference co-organised by City University of Hong Kong (CityU) and Nature Conferences, the preeminent series curated by the highly prestigious science journal Nature and Nature journals.

Chula’s Own Solar Cell Project High-powered and Diverse Formats that Meet World Standards

Chula’s researchers have garnered themselves a world-class reward for their latest solar cell project which increases the capacity of electricity production and can be applied to numerous types of merchandise. These new solar cells are guaranteed to meet international standards and develop clean energy for society.

HKIAS Senior Fellow Professor George Fu Gao was elected Foreign Member of The Royal Society and conferred an honorary doctorate by the City University of Macau

Professor George Fu Gao, HKIAS Senior Fellow and the Director-General of the Chinese Center for Disease Control and Prevention in China, was recently elected a Foreign Member of the Royal Society for his contributions in the field of infection and immunity, particularly relating to emerging viral infections, have helped to improve our understanding of major threats to human health.

Frontier supercomputer debuts as world’s fastest, breaking exascale barrier

The Frontier supercomputer at the Department of Energy’s Oak Ridge National Laboratory earned the top ranking today as the world’s fastest on the 59th TOP500 list, with 1.1 exaflops of performance. The system is the first to achieve an unprecedented level of computing performance known as exascale, a threshold of a quintillion calculations per second.

Adaptive swim classes build confidence, safety skills for autistic children

Based on the positive results of a new pilot study offering personalized aquatic occupational therapy for 19 autistic children, researchers at The Ohio State University Wexner Medical Center and College of Medicine will expand the program to include 36 autistic children over the next year.

Brookhaven Lab’s Chang-Yong Nam Named a Battelle ‘Inventor of the Year’

Materials scientist Chang-Yong Nam of the Center for Functional Nanomaterials (CFN)—a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Brookhaven National Laboratory—has been recognized as an “Inventor of the Year” by the global science and technology organization Battelle.

Deadly arrhythmia trifecta: Salt, swelling, and leaky sodium channels

Cardiovascular researchers at Virginia Tech’s Fralin Biomedical Research Institute at VTC have published a new study describing how deadly arrhythmias arise from elevated sodium levels, heart tissue irritation and swelling, and sodium channel abnormalities associated with Long QT syndrome. The scientists were the first to examine the impacts of heart tissue swelling and blood chemistry in relation to the syndrome.

Ancient Viral Elements Embedded in Human Genome Not From Fossil Retrovirus

Using a next generation sequencing analysis to examine human endogenous retrovirus (HERV) integration sites, researchers from Kumamoto University, the National Institute of Genetics (Japan), and the University of Michigan (USA) have discovered that these ancient retroviruses can undergo retrotransposition (DNA sequence insertion with RNA mediation) into iPS cells.

Cedars-Sinai Investigators ID Gene Critical to Human Immune Response

Cedars-Sinai investigators have identified a gene that plays an essential role in the innate human immune system. The gene, NLRP11, helps activate the inflammatory response that tells the body’s white blood cells to go on the attack against a foreign presence.